Yesterday, Neola Medical released its interim report for January-September 2022. In conjunction with this, CEO Hanna Sjöström and CFO Christian Gyllenberg presented the Q3 report in a videoconference. In addition to providing an overview of the company’s financial position and the key events of the quarter, they also discussed the clinical study recently completed in Ireland involving 100 newborns and the rights issue carried out in October. Following the presentation, questions received were answered in a brief Q&A session.

The recorded presentation is available for viewing here.